Innovation Authority Invites Israeli Companies to Participate in Pilot with World-Leading Medical Centers
The IIA program will offer financial support of up to 50% of the project’s approved research and development budget.
The Israel Innovation Authority (IIA) and select world-renowned hospitals have announced a new partnership via an international Call for Proposals focusing on healthcare pilots. The IIA program will offer financial support of up to 50% of the project’s approved research and development budget.
Israeli companies are invited to submit proposals to implement pilot projects and to analyze, adapt, and optimize health-focused technologies, services and products in the clinical environments of some of the world’s leading hospitals: Germany's Charité – Universitätsmedizin and the U.S.’s Mayo Clinic, Hartford HealthCare, and Thomas Jefferson University.
According to the Innovation Authority, the government's tech investment arm, the goals of this Call for Proposals is to encourage global collaboration, accelerating the availability of medical innovations to the public, upping accessibility of Israeli healthcare technologies within the international market, and promoting the development of new discoveries to benefit patients worldwide. Companies chosen through this Call for Proposals will receive a project grant of up to 50% of the approved research and development budget from the IIA, in addition to access to partnering hospitals’ resources and know-how in the fields of clinical treatment, clinical research and R&D activities.
Aharon Aharon, CEO of the IIA. Photo: Orel Cohen
In response to a question from Calcalist, the IIA said that no ceiling has been set regarding the size of its investment and that the budget will depend on the number of proposals submitted. The IIA said that it is predicting an annual budget of around NIS 8-10 million shekels (approximately $2.28-2.85 million).
“Today, when healthcare tops the global agenda, four of the world’s leading medical centers are giving a significant boost to Israel’s healthcare industry – offering a vote of confidence in the abilities of Israeli companies by expressing interest in developing, adopting and integrating Israeli technologies in their diverse medical centers," said Avi Luvton, head of the Israel Innovation Authority’s International Collaborations Division. "We are proud to offer Israeli companies direct access to several large-scale international health organizations for planned collaborative activities. The Israel Innovation Authority, together with these medical centers, strives to promote and support quality collaborations that advance research and healthcare capabilities across a range of fields.”